BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19053007)

  • 1. [Perianal fistulas in Crohn's disease--biologicals and surgery: is it worthwhile?].
    Bode M; Eder S; Schürmann G
    Z Gastroenterol; 2008 Dec; 46(12):1376-83. PubMed ID: 19053007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
    Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
    Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
    Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab treatment for anal fistula in patients with Crohn's disease.
    Higashi D; Futami K; Egawa Y; Hirano K; Tomiyasu T; Ishibashi Y; Simomura T; Nii K; Kuroki H; Maekawa T; Ono Y; Matsui T
    Anticancer Res; 2009 Mar; 29(3):927-33. PubMed ID: 19414329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: The medical treatment of Crohn's perianal fistulas.
    Schwartz DA; Herdman CR
    Aliment Pharmacol Ther; 2004 May; 19(9):953-67. PubMed ID: 15113362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practice.
    Bourikas LA; Koutroubakis IE
    Curr Drug Targets; 2010 Feb; 11(2):187-97. PubMed ID: 19916954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.
    Orlando A; Colombo E; Kohn A; Biancone L; Rizzello F; Viscido A; Sostegni R; Benazzato L; Castiglione F; Papi C; Meucci G; Riegler G; Mocciaro F; Cassinotti A; Cosintino R; Geremia A; Morselli C; Angelucci E; Lavagna A; Rispo A; Bossa F; Scimeca D; Cottone M;
    Dig Liver Dis; 2005 Aug; 37(8):577-83. PubMed ID: 15886081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab in fistulizing Crohn's disease.
    Osterman MT; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fistulizing Crohn's disease.
    Judge TA; Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):421-54, xi-xii. PubMed ID: 15177547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas.
    Ng SC; Plamondon S; Gupta A; Burling D; Kamm MA
    Aliment Pharmacol Ther; 2009 Oct; 30(7):757-66. PubMed ID: 19575762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical options in the treatment of perianal Crohn's disease].
    Danelli P; Bartolucci C; Sampietro GM; Panizzo V; Sartani A; Maconi G; Parente E; Taschieri AM
    Ann Ital Chir; 2003; 74(6):635-40. PubMed ID: 15206804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH.
    Crandall W; Hyams J; Kugathasan S; Griffiths A; Zrubek J; Olson A; Liu G; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2009 Aug; 49(2):183-90. PubMed ID: 19561542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fistulizing Crohn's disease.
    Felley C; Mottet C; Juillerat P; Pittet V; Froehlich F; Vader JP; Michetti P; Gonvers JJ
    Digestion; 2007; 76(2):109-12. PubMed ID: 18239401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perianal fistulas in Crohn's disease: MRI diagnosis and surgical planning: MRI in fistulazing perianal Crohn's disease.
    Szurowska E; Wypych J; Izycka-Swieszewska E
    Abdom Imaging; 2007 Nov; 32(6):705-18. PubMed ID: 17334876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion.
    Kasparek MS; Glatzle J; Temeltcheva T; Mueller MH; Koenigsrainer A; Kreis ME
    Dis Colon Rectum; 2007 Dec; 50(12):2067-74. PubMed ID: 17680311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perianal inflammatory conditions in inflammatory bowel disease.
    Stein BL; Gordon PH
    Curr Opin Gen Surg; 1993; ():141-6. PubMed ID: 7583950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.